Red Marrow Radiation Dose Adjustment Using Plasma FLT3-L Cytokine Levels: Improved Correlations Between Hematologic Toxicity and Bone Marrow Dose for Radioimmunotherapy Patients
Jeffry A. Siegel, PhD1,
Dion Yeldell, BS2,
David M. Goldenberg, ScD, MD2,
Michael G. Stabin, PhD3,
Richard B. Sparks, PhD4,
Robert M. Sharkey, PhD2,
Arnold Brenner, DO2 and
Rosalyn D. Blumenthal, PhD2
1 Nuclear Physics Enterprises, Cherry Hill, New Jersey
2 Garden State Cancer Center, Belleville, New Jersey
3 Vanderbilt University School of Medicine, Nashville, Tennessee
4 CDE Dosimetry Services, Inc., Knoxville, Tennessee

View larger version (14K):
[in a new window]
|
FIGURE 1. Comparisons of PN with FLT3-Ladjusted predictors of toxicity.
|
|

View larger version (14K):
[in a new window]
|
FIGURE 2. Comparisons of 1/PN with FLT3-Ladjusted predictors of toxicity.
|
|
Copyright © 2003 by the Society of Nuclear Medicine.